The estimated net worth of Dr. Nello Mainolfi M.D., Ph.D. is at least $41,243,534 as of 1 Jul 2024. He owns shares worth
$20,352,078 as insider, has earned $17,560,976
from insider trading and has received compensation worth at least
$3,330,480 in Kymera Therapeutics, Inc..
What is the salary of Nello Mainolfi M.D., Ph.D.?
Dr. Nello Mainolfi M.D., Ph.D. salary is $832,620 per year
as Co-Founder, Pres, Chief Executive Officer & Director in Kymera Therapeutics, Inc..
How old is Nello Mainolfi M.D., Ph.D.?
Dr. Nello Mainolfi M.D., Ph.D. is 46 years old, born in 1979.
What stocks does Nello Mainolfi M.D., Ph.D. currently own?
As insider, Dr. Nello Mainolfi M.D., Ph.D. owns shares in one company:
Co-Founder, Pres, Chief Executive Officer & Director
478,085
$42.57
$20,352,078
What does Kymera Therapeutics, Inc. do?
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa, atopic dermatitis, macrophage activation syndrome, general pustular psoriasis, and rheumatoid arthritis; IRAKIMiD program to treat MYD88-mutated diffuse large B cell lymphoma; STAT3 program for the treatment of hematologic malignancies and solid tumors, as well as autoimmune diseases and fibrosis; and MDM2 program to treat hematological malignancies and solid tumors. The company was incorporated in 2015 and is headquartered in Watertown, Massachusetts.
Dr. Nello Mainolfi M.D., Ph.D. has made 32 insider trades between 2021-2024, according to the Form 4 filled with the SEC.
The largest trade he's
ever made was exercising 48,000 units of KYMR stock
on 8 Jul 2021. As of 1 Jul 2024
he still owns at least 478,085 units of KYMR stock.
Transaction
Date
Security
Shares
Price per share
Total value
Source
Option
Common Stock
18,773
$5.33
$100,060
Option
Stock Option (Right to Buy)
18,773
$5.33
$100,060
Option
Common Stock
14,413
$2.08
$29,979
Option
Stock Option (Right to Buy)
14,413
$2.08
$29,979
Option
Common Stock
9,000
$2.08
$18,720
Option
Stock Option (Right to Buy)
9,000
$2.08
$18,720
Option
Common Stock
2,368
$2.08
$4,925
Option
Common Stock
17,632
$2.08
$36,675
Option
Stock Option (Right to Buy)
17,632
$2.08
$36,675
Option
Stock Option (Right to Buy)
2,368
$2.08
$4,925
Option
Common Stock
12,000
$2.08
$24,960
Option
Stock Option (Right to Buy)
12,000
$2.08
$24,960
Option
Common Stock
10,000
$2.08
$20,800
Option
Stock Option (Right to Buy)
10,000
$2.08
$20,800
Option
Stock Option (Right to Buy)
27,676
$2.08
$57,566
Option
Common Stock
27,676
$2.08
$57,566
Option
Common Stock
32,056
$2.08
$66,676
Option
Stock Option (Right to Buy)
32,056
$2.08
$66,676
Option
Stock Option (Right to Buy)
20,000
$2.08
$41,600
Option
Common Stock
20,000
$2.08
$41,600
Option
Stock Option (Right to Buy)
10,000
$2.08
$20,800
Option
Common Stock
10,000
$2.08
$20,800
Option
Common Stock
8,612
$2.08
$17,913
Sale
Common Stock
8,612
$52.64
$453,353
Option
Stock Option (Right to Buy)
48,000
$2.08
$99,840
Option
Common Stock
16,923
$2.08
$35,200
Sale
Common Stock
16,923
$54.38
$920,340
Option
Common Stock
22,465
$2.08
$46,727
Sale
Common Stock
22,465
$53.8
$1,208,595
Option
Common Stock
8,000
$2.08
$16,640
Option
Stock Option (Right to Buy)
8,000
$2.08
$16,640
Option
Stock Option (Right to Buy)
48,000
$2.08
$99,840
Sale
Common Stock
6,456
$54.04
$348,876
Option
Common Stock
6,456
$2.08
$13,428
Sale
Common Stock
41,544
$58.52
$2,431,280
Option
Common Stock
41,544
$2.08
$86,412
Option
Common Stock
12,000
$2.08
$24,960
Option
Stock Option (Right to Buy)
12,000
$2.08
$24,960
Option
Common Stock
1,037
$60.03
$62,253
Option
Stock Option (Right to Buy)
1,037
$60.03
$62,253
Sale
Common Stock
1,037
$60.03
$62,253
Option
Common Stock
5,669
$2.08
$11,792
Option
Stock Option (Right to Buy)
5,669
$2.08
$11,792
Sale
Common Stock
5,669
$2.08
$11,792
Option
Stock Option (Right to Buy)
23,456
$2.08
$48,788
Sale
Common Stock
23,456
$61.23
$1,436,211
Option
Common Stock
23,456
$2.08
$48,788
Option
Stock Option (Right to Buy)
6,279
$60.07
$377,167
Sale
Common Stock
6,279
$60.07
$377,167
Option
Common Stock
6,279
$60.07
$377,167
Option
Stock Option (Right to Buy)
680
$2.08
$1,414
Sale
Common Stock
680
$2.08
$1,414
Option
Common Stock
680
$2.08
$1,414
Sale
Common Stock
3,864
$60.15
$232,408
Option
Common Stock
3,864
$60.15
$232,408
Option
Stock Option (Right to Buy)
3,864
$60.15
$232,408
Option
Common Stock
9,015
$2.08
$18,751
Option
Stock Option (Right to Buy)
9,015
$2.08
$18,751
Sale
Common Stock
9,015
$2.08
$18,751
Sale
Common Stock
48,000
$50.37
$2,417,520
Sale
Common Stock
48,000
$50.37
$2,417,520
Sale
Common Stock
48,000
N/A
N/A
Option
Stock Option (Right to Buy)
48,000
N/A
N/A
Option
Common Stock
48,000
N/A
N/A
Option
Common Stock
40,000
$2.08
$83,200
Option
Stock Option (Right to Buy)
40,000
$2.08
$83,200
Option
Common Stock
23,009
$2.08
$47,859
Sale
Common Stock
23,009
$51.54
$1,185,907
Sale
Common Stock
23,009
$51.54
$1,185,907
Option
Stock Option (Right to Buy)
23,009
$2.08
$47,859
Option
Common Stock
5,752
$50.02
$287,721
Sale
Common Stock
5,752
$50.02
$287,721
Option
Stock Option (Right to Buy)
5,752
$50.02
$287,721
Option
Stock Option (Right to Buy)
270
$50
$13,500
Sale
Common Stock
270
$50
$13,500
Option
Common Stock
270
$50
$13,500
Option
Stock Option (Right to Buy)
12,724
$2.08
$26,466
Option
Common Stock
12,724
$2.08
$26,466
Sale
Common Stock
12,724
$2.08
$26,466
Option
Common Stock
15,000
N/A
N/A
Option
Stock Option (Right to Buy)
15,000
N/A
N/A
Option
Stock Option (Right to Buy)
8,245
N/A
N/A
Sale
Common Stock
8,245
N/A
N/A
Option
Common Stock
8,245
N/A
N/A
Option
Common Stock
2,768
$40.18
$111,229
Option
Stock Option (Right to Buy)
2,768
$40.18
$111,229
Sale
Common Stock
2,768
$40.18
$111,229
Option
Common Stock
680
$40.01
$27,207
Option
Stock Option (Right to Buy)
680
$40.01
$27,207
Sale
Common Stock
680
$40.01
$27,207
Sale
Common Stock
10,959
$2.08
$22,795
Option
Common Stock
10,959
$2.08
$22,795
Option
Stock Option (Right to Buy)
10,959
$2.08
$22,795
Option
Common Stock
6,653
N/A
N/A
Option
Stock Option (Right to Buy)
6,653
$20
$133,067
Option
Stock Option (Right to Buy)
6,653
N/A
N/A
Option
Common Stock
6,653
$20
$133,067
Sale
Common Stock
653
N/A
N/A
Sale
Common Stock
4,940
N/A
N/A
Option
Stock Option (Right to Buy)
4,940
$2.08
$10,275
Option
Common Stock
4,940
$2.08
$10,275
Option
Stock Option (Right to Buy)
15,000
$2.08
$31,200
Option
Common Stock
15,000
$2.08
$31,200
Sale
Common Stock
15,267
N/A
N/A
Option
Stock Option (Right to Buy)
15,267
$2.08
$31,755
Option
Common Stock
15,267
$2.08
$31,755
Sale
Common Stock
15,267
$32.8
$500,788
Option
Stock Option (Right to Buy)
22,794
N/A
N/A
Option
Common Stock
22,794
$2.08
$47,412
Sale
Common Stock
22,794
$33.89
$772,375
Sale
Common Stock
22,794
$17.09
$389,618
Option
Stock Option (Right to Buy)
9,939
N/A
N/A
Sale
Common Stock
9,939
$35.21
$349,992
Option
Common Stock
9,939
$2.08
$20,673
Sale
Common Stock
9,939
$35.21
$349,992
Kymera Therapeutics key executives
Kymera Therapeutics, Inc. executives and other stock owners filed with the SEC:
Dr. Bruce L. Booth D.Phil., Ph.D.(51)Co-Founder & Chairman
